Komori
Tabio (2668) · Fact¥14 million in R&D expenses for the interim period

Quarter-to-date research and development expenses: ¥17 million

First written in FY2017-Q3. . Latest entry: FY2027-H1.

35entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2017-Q3 – FY2027-H12017: 420172018: 420182019: 420192020: 420202021: 420212022: 420222023: 420232024: 320242025: 220252026: 22026
Same theme, other companies
Recognition and Disclosure of R&D ExpensesA theme 73 companies write about · 0 as a headwind · 21 as a tailwind

49 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 73 companies compared. The sentences above are computed from all 73.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1¥14 million in R&D expenses for the interim periodAnnual report

    「Total R&D expenses for the interim consolidated accounting period were ¥14 million.」

    R&D expenses for the interim consolidated accounting period were disclosed at ¥14 million in total.
  2. FY2026Annual R&D expenses of ¥11 millionAnnual report

    「Total R&D expenses for the current consolidated fiscal year came to ¥11 million.」

    Full-year R&D expenses related to organic cotton produced in Nara Prefecture and proprietary yarn came to ¥11 million.
  3. FY2026-H1Interim R&D expenses: ¥9 millionAnnual report

    「Total R&D expenses for the current interim consolidated accounting period were ¥9 million.」

    Total R&D expenses for the interim consolidated accounting period came to ¥9 million.
  4. FY2025Annual R&D expenses of ¥24 millionAnnual report

    「Total R&D expenses for the consolidated fiscal year totaled ¥24 million.」

    Annual R&D expenses related to organic cotton produced in Nara Prefecture and the company's proprietary yarn amounted to ¥24 million.
  5. FY2025-H1Interim R&D expenses of ¥11 millionAnnual report

    「Total R&D expenses for the current interim consolidated accounting period were ¥11 million.」

    Total R&D expenses for the interim consolidated accounting period were disclosed as ¥11 million.
  6. FY2025-Q1First-quarter R&D expenses of ¥5 millionAnnual report

    「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal year were ¥5 million.」

    The company has disclosed total R&D expenses of ¥5 million for the cumulative period through the first quarter.
  7. FY2024-Q3Cumulative R&D expenses through the third quarter of ¥16 millionAnnual report

    「R&D expenses for the cumulative period of the current fiscal year through the third quarter totaled ¥16 million.」

    The company has disclosed total R&D expenses of ¥16 million for the cumulative period through the third quarter.
  8. FY2024-Q2First-half R&D expenses of ¥12 millionAnnual report

    「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥12 million.」

    The company has disclosed total R&D expenses of ¥12 million for the cumulative period through the second quarter.
  9. FY2024-Q1First-quarter R&D expenses of ¥6 millionAnnual report

    「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal year were ¥6 million.」

    The company has disclosed total R&D expenses of ¥6 million for the cumulative period through the first quarter.
  10. FY2023Annual R&D expenses of ¥17 millionAnnual report

    「Total R&D expenses for the consolidated fiscal year totaled ¥17 million.」

    The company disclosed annual R&D expenses of ¥17 million.
  11. FY2023-Q3Cumulative R&D expenses through the third quarter of ¥12 millionAnnual report

    「R&D expenses for the cumulative period of the current fiscal year through the third quarter totaled ¥12 million.」

    The company has disclosed total R&D expenses of ¥12 million for the cumulative period through the third quarter.
  12. FY2023-Q2First-half R&D expenses of ¥8 millionAnnual report

    「R&D expenses for the cumulative period of the current fiscal year through the second quarter totaled ¥8 million.」

    The company has disclosed total R&D expenses of ¥8 million for the cumulative period of the current fiscal year through the second quarter.
  13. FY2023-Q1First-quarter R&D expenses of ¥3 millionAnnual report

    「R&D expenses for the cumulative period of the current fiscal year through the first quarter totaled ¥3 million.」

    The company has disclosed total R&D expenses of ¥3 million for the cumulative period through the first quarter.
  14. FY2022Annual R&D expenses of ¥20 millionAnnual report

    「Total R&D expenses for the consolidated fiscal year totaled ¥20 million.」

    Annual total R&D expenses amounted to ¥20 million.
  15. FY2022-Q3Cumulative R&D expenses through the third quarter of ¥15 millionAnnual report

    「R&D expenses for the cumulative period of the current fiscal year through the third quarter totaled ¥15 million.」

    The company has disclosed total R&D expenses of ¥15 million for the cumulative period through the third quarter.
  16. FY2022-Q2First-half R&D expenses of ¥9 millionAnnual report

    「R&D expenses for the cumulative period of the current fiscal year through the second quarter totaled ¥9 million.」

    The company has disclosed total R&D expenses of ¥9 million for the cumulative period through the second quarter.
  17. FY2022-Q1¥4 Million in Research and Development Expenses in the First QuarterAnnual report

    「R&D expenses for the cumulative period of the current fiscal year through the first quarter totaled ¥4 million.」

    The company has disclosed total R&D expenses of ¥4 million for the cumulative period through the first quarter.
  18. FY2021Annual R&D expenses of ¥29 millionAnnual report

    「Total R&D expenses for the consolidated fiscal year totaled ¥29 million.」

    Annual total R&D expenses amounted to ¥29 million.
  19. FY2021-Q3Cumulative R&D expenses through the third quarter of ¥22 millionAnnual report

    「R&D expenses for the cumulative period of the current fiscal year through the third quarter totaled ¥22 million.」

    The company has disclosed total R&D expenses of ¥22 million for the cumulative period of the current fiscal year through the third quarter.
  20. FY2021-Q2First-half R&D expenses of ¥14 millionAnnual report

    「R&D expenses for the cumulative period of the current fiscal year through the second quarter totaled ¥14 million.」

    The company has disclosed total R&D expenses of ¥14 million for the cumulative period of the current fiscal year through the second quarter.
  21. FY2021-Q1First-quarter R&D expenses of ¥7 millionAnnual report

    「R&D expenses for the cumulative period of the current fiscal year through the first quarter totaled ¥7 million.」

    Total R&D expenses for the cumulative period through the first quarter amounted to ¥7 million.
  22. FY2020Annual R&D expenses of ¥28 millionAnnual report

    「Total R&D expenses for the consolidated fiscal year totaled ¥28 million.」

    Annual total R&D expenses amounted to ¥28 million.
  23. FY2020-Q3Cumulative R&D expenses through the third quarter of ¥21 millionAnnual report

    「R&D expenses for the cumulative period of the current fiscal year through the third quarter totaled ¥21 million.」

    Total R&D expenses for the cumulative period through the third quarter amounted to ¥21 million.
  24. FY2020-Q2First-half R&D expenses of ¥13 millionAnnual report

    「R&D expenses for the cumulative period of the current fiscal year through the second quarter totaled ¥13 million.」

    Total R&D expenses for the cumulative period through the second quarter amounted to ¥13 million.
  25. FY2020-Q1First-quarter R&D expenses of ¥7 millionAnnual report

    「R&D expenses for the cumulative period of the current fiscal year through the first quarter totaled ¥7 million.」

    Total R&D expenses for the cumulative period through the first quarter amounted to ¥7 million.
  26. FY2019Annual R&D expenses of ¥24 millionAnnual report

    「Total R&D expenses for the consolidated fiscal year totaled ¥24 million.」

    Annual R&D expenses related to organic cotton produced in Nara Prefecture and the company's proprietary yarn amounted to ¥24 million.
  27. FY2019-Q3Cumulative R&D expenses through the third quarter of ¥18 millionAnnual report

    「R&D expenses for the cumulative period of the current fiscal year through the third quarter totaled ¥18 million.」

    The company has disclosed total R&D expenses of ¥18 million for the cumulative period of the current fiscal year through the third quarter.
  28. FY2019-Q2First-half R&D expenses of ¥12 millionAnnual report

    「Total research and development expenses for the cumulative second quarter of the current consolidated fiscal year were ¥12 million.」

    The company has disclosed R&D expenses of ¥12 million for the cumulative period of the current fiscal year through the second quarter.
  29. FY2019-Q1Quarterly R&D expenses of ¥6 millionAnnual report

    「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal year were ¥6 million.」

    The company has disclosed total R&D expenses of ¥6 million for the cumulative period of the current fiscal year through the first quarter.
  30. FY2018Annual R&D expenses of ¥28 millionAnnual report

    「Total R&D expenses for the consolidated fiscal year totaled ¥27 million.」

    The company has disclosed annual total R&D expenses of ¥27 million.
  31. FY2018-Q3Cumulative R&D expenses through the third quarter of ¥20 millionAnnual report

    「R&D expenses for the cumulative period of the current fiscal year through the third quarter totaled ¥20 million.」

    The company has disclosed total R&D expenses of ¥20 million for the cumulative period of the current fiscal year through the third quarter.
  32. FY2018-Q2First-half R&D expenses of ¥11 millionAnnual report

    「R&D expenses for the cumulative period of the current fiscal year through the second quarter totaled ¥11 million.」

    The company has disclosed total R&D expenses of ¥11 million for the cumulative period of the current fiscal year through the second quarter.
  33. FY2018-Q1Quarterly R&D expenses of ¥5 millionAnnual report

    「Total research and development expenses for the cumulative first quarter of the current consolidated fiscal year were ¥5 million.」

    The company has disclosed total R&D expenses of ¥5 million for the cumulative period of the current fiscal year through the first quarter.
  34. FY2017Annual R&D expenses of ¥22 millionAnnual report

    「Total R&D expenses for the consolidated fiscal year totaled ¥22 million.」

    Annual total R&D expenses amounted to ¥22 million.
  35. FY2017-Q3First statedAnnual report

    「R&D expenses for the cumulative period of the current fiscal year through the third quarter totaled ¥17 million.」

    The company has disclosed total R&D expenses of ¥17 million for the cumulative period of the current fiscal year through the third quarter.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Tabio yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.